Several studies have demonstrated that increased CXCL10 expression correlates with improved prognosis in various human cancers, including high‐grade serous ovarian carcinoma, colorectal cancer (CRC), hepatocellular carcinoma, and breast carcinoma [15, 16, 17, 18]. The gene discussed is CXCL10; the disease is breast carcinoma.